• Publications
  • Influence
Immune-based Therapies for Non-small Cell Lung Cancer.
Lung cancer is the leading cause of cancer-related death worldwide. Treatment of non-small cell lung cancer has evolved tremendously over the past decade. Specifically, immune checkpoint inhibitorsExpand
  • 25
  • 2
Acute Graft Versus Host Disease: A Comprehensive Review.
Acute graft versus host disease (aGVHD) remains the second leading cause of death following allogeneic hematopoietic stem cell transplant (AHSCT). Over the last five years, the progress inExpand
  • 66
  • 1
The role of mutant IDH1 and IDH2 inhibitors in the treatment of acute myeloid leukemia
For decades, researchers have looked into the pathophysiology of acute myeloid leukemia (AML). With the advances in molecular techniques, the two-hit hypothesis was replaced by a multi-hit model,Expand
  • 38
  • 1
PD-1 signaling and inhibition in AML and MDS
Acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) are clinically and molecularly heterogeneous clonal myeloid disorders with a poor prognosis especially in the relapsed refractoryExpand
  • 10
  • 1
Disseminated intravascular coagulation-like reaction following rituximab infusion
Rituximab generally is a well-tolerated medication used in a variety of haematological and autoimmune conditions. The safety profile of the medication has been reviewed in the literature. InfusionExpand
  • 7
  • 1
Chronic Myeloid Leukemia as Secondary Malignancy Following the Treatment of Hodgkin Lymphoma: A Case Series
Secondary malignancies are relatively common and clinically important phenomena following both chemotherapy and radiotherapy. The majority of these cases are acute leukemias, the occurrence of whichExpand
  • 1
  • 1
Evaluating ivosidenib for the treatment of relapsed/refractory AML: design, development, and place in therapy
Improvements in the last decade in understanding the molecular mechanisms underlying acute myeloid leukemia (AML) have emphasized that treatment regimens should be personalized with agents that canExpand
  • 11
  • Open Access
Sinusoidal Obstruction Syndrome (Veno-occlusive Disease) Following Hematopoietic Stem Cell Transplant: Insights and Therapeutic Advances.
Hepatic sinusoidal obstruction syndrome (SOS) is a rare fatal clinical entity seen following hematopoietic stem cell transplant (HSCT). It is more commonly reported to occur following allogeneic HSCTExpand
  • 3
Bariatric venous thromboembolism prophylaxis: an update on the literature
ABSTRACT Introduction: Rates of obesity have been increasing worldwide and with the current situation obesity now represents an epidemic. Bariatric surgery is one the most effective ways to helpExpand
  • 3
Post-Transfusion Purpura: A Case Report of an Underdiagnosed Phenomenon
Post-transfusion purpura is a rare transfusion-related complication that often goes undiagnosed. It is due to alloimmunization against platelet antigens which leads to acute profound thrombocytopeniaExpand
  • 3
  • Open Access